Vimarsana
Biggest News Aggregation in the World

Avidity Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Avidity Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Avidity Partners Today - Breaking & Trending Today

Context Therapeutics Announces $100 Million Private Placement - Vimarsana News

Context Therapeutics Announces $100 Million Private Placement

Financing includes new and existing leading healthcare investors

Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines - Vimarsana News

Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines

SAN DIEGO--(BUSINESS WIRE)--Apr 24, 2024--

Endeavor BioMedicines Raises $132.5M in Series C Financing - Vimarsana News

Endeavor BioMedicines Raises $132.5M in Series C Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

TORL secures $158m for oncology pipeline development - Vimarsana News

TORL secures $158m for oncology pipeline development

Clinical-stage biotechnology company TORL BioTherapeutics has announced the closure of an oversubscribed $158m Series B-2 financing round.

TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline - Vimarsana News

TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline

$158M Series B-2 Financing led by Deep Track Capital, with new participation from leading global biotechnology investors including RA Capital Management,...